"
Team:Aachen/Attributions
From 2014.igem.org
(→Members) |
(→Members) |
||
| (6 intermediate revisions not shown) | |||
| Line 63: | Line 63: | ||
<i> Molecular and Applied Biotechnology </i> | <i> Molecular and Applied Biotechnology </i> | ||
<br/><br/> | <br/><br/> | ||
| - | The Patience | + | The Patience himself |
<br/><br/> | <br/><br/> | ||
<!-- click for more information --> | <!-- click for more information --> | ||
| Line 118: | Line 118: | ||
<a href="https://2014.igem.org/User:R.hanke" style="color:black"> | <a href="https://2014.igem.org/User:R.hanke" style="color:black"> | ||
<div class="team-item team-info" style="height: 180px; width: 180px;"> | <div class="team-item team-info" style="height: 180px; width: 180px;"> | ||
| - | + | <br/> | |
<b> René Hanke </b> | <b> René Hanke </b> | ||
<br/><br/> | <br/><br/> | ||
<i> Molecular and Applied Biotechnology </i> | <i> Molecular and Applied Biotechnology </i> | ||
<br/><br/> | <br/><br/> | ||
| - | + | Chief of Communication | |
<br/><br/> | <br/><br/> | ||
<!-- click for more information --> | <!-- click for more information --> | ||
| Line 133: | Line 133: | ||
<a href="https://2014.igem.org/User:PatrickO" style="color:black"> | <a href="https://2014.igem.org/User:PatrickO" style="color:black"> | ||
<div class="team-item team-info" style="height: 180px; width: 180px;"> | <div class="team-item team-info" style="height: 180px; width: 180px;"> | ||
| - | + | ||
| - | <b> Patrick | + | <b> Patrick Opdensteinen </b> |
<br/><br/> | <br/><br/> | ||
<i> Molecular and Applied Biotechnology </i> | <i> Molecular and Applied Biotechnology </i> | ||
| Line 309: | Line 309: | ||
<div align="center"> | <div align="center"> | ||
{|cellpadding="25" | {|cellpadding="25" | ||
| - | |[[File:Logo_Buergerstiftung-Aachen_hoch.jpg|159px|center | + | |[[File:Logo_Buergerstiftung-Aachen_hoch.jpg|159px|center|Bürgerstiftung Aachen]] |
| - | |[[File:Aachen_Niersverband_Firmenlogo.jpg|318px | + | |[[File:Aachen_Niersverband_Firmenlogo.jpg|318px|Niersverband]] |
|} | |} | ||
{|cellpadding="13" | {|cellpadding="13" | ||
| - | |[[File:Aachen_Genscript_Logo.png|240px | + | |[[File:Aachen_Genscript_Logo.png|240px|Genscript]] |
| - | |[[File:Aachen_Eurofinsgenomics.png|193px | + | |[[File:Aachen_Eurofinsgenomics.png|193px|Eurofins Genomics]] |
| - | |[[File:Aachen_Labomedic_Logo.jpg|256px | + | |[[File:Aachen_Labomedic_Logo.jpg|256px|Labomedic]] |
|} | |} | ||
{|cellpadding="35" | {|cellpadding="35" | ||
| - | |[[File:Aachen_bmbf.jpg|326px | + | |[[File:Aachen_bmbf.jpg|326px|BMBF]] |
| - | |[[File:Aachen_idt_.png|217px | + | |[[File:Aachen_idt_.png|217px|IDT]] |
|} | |} | ||
{|cellpadding="25" | {|cellpadding="25" | ||
| - | |[[File:M2p_labs_logo.jpg|103px | + | |[[File:M2p_labs_logo.jpg|103px|m2p labs]] |
| - | |[[File:Aachen_Roth_Logo.png|109px | + | |[[File:Aachen_Roth_Logo.png|109px|Carl Roth]] |
| - | |[[File:Aachen_ProRWTH_logo.png|121px | + | |[[File:Aachen_ProRWTH_logo.png|121px|pro RWTH]] |
|} | |} | ||
{|cellpadding="25" | {|cellpadding="25" | ||
Latest revision as of 13:47, 9 September 2015
|
|
Prof. Blank focuses his research on fundamental and applied aspects of microbial metabolism. Of specific interest is the interaction between the metabolic network and the introduced genetic and environmental perturbations. The research on in silico/in vivo metabolic network operations is aimed at a deeper understanding of cell function, with the ultimate goal of rational cell engineering.
Prof. Wiechert's main area of work lies within the field of applied systems bio(techno)logy of microorganisms with a special focus on methodological developments for quantitative biology. Characteristics of his research work are a close integration of experimental and theoretical work within multi disciplinary projects. As the head of the Systems Biotechnology research division at Forschungszentrum Jülich, he is developing methods for quantitative metabolomics, fluxomics and proteomics including model based mathematical methods for experimental design, parameter estimation, and process optimization in biotechnological systems. Future work will also incorporate micro fluidic methods for single cell analysis. In general, all research results are used to drive forward the process of gaining knowledge in the course of an iterative improvement of industrial production systems. This proceeds in close cooperation of all working groups at the IBG-1. Together with industrial partners also diverse examples from industry are investigated and further developed. Read more about Prof. Wiechert's work on the [http://www.fz-juelich.de/SharedDocs/Personen/IBG/IBG-1/EN/Research_groups/general/wiechert.html/ IBG-1 website].
The Schwaneberg Group seeks to be at the research frontier in the interdisciplinary field of directed protein evolution by developing novel methods for generating diversity at the gene level, analyzing consequence of mutational biases on the protein level and developing novel high-throughput screening systems that will ultimately lead to tailored-biocatalysts for significant applications in industry. They train students in the cutting edge technologies of laboratory evolution, biocatalyst engineering and high throughput screening methodologies. The Schwaneberg Group believes in integrating fundamental principles of protein design with environmental awareness in their research and seeks to promote international scientific collaborations. Read more about Prof. Schwaneberg and his work on the [http://www.biotec.rwth-aachen.de/ Schwaneberg Group's website].
|
|
